Nabriva Therapeutics
NBRV
#10435
Rank
S$5.75 M
Marketcap
S$1.80
Share price
0.00%
Change (1 day)
-72.71%
Change (1 year)

Earnings for Nabriva Therapeutics (NBRV)

Earnings in 2023 (TTM): -S$72.34 Million

According to Nabriva Therapeutics 's latest financial reports the company's current earnings are S$35.58 Million. In 2022 the company made an earning of -S$70.39 Million a decrease over its 2021 earnings that were of -S$61.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nabriva Therapeutics from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$72.34 Million2.76%
2022 -S$70.39 Million13.6%
2021 -S$61.97 Million-29.4%
2020 -S$87.77 Million-16.11%
2019 -S$0.11 Billion-27.95%
2018 -S$0.15 Billion57.16%
2017 -S$92.4 Million31.39%
2016 -S$70.32 Million77.75%
2015 -S$39.57 Million93.16%
2014 -S$20.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 180.07%๐Ÿ‡บ๐Ÿ‡ธ USA